Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Golgi-associated lysophospholipid acyltransferase, scientifically identified as 1-acyl-sn-glycerol-3-phosphate acyltransferase 3 (AGPAT3 or LPAAT3), is an integral membrane enzyme localized to the Golgi complex and endoplasmic reticulum [10, 14]. It plays a critical role in the Lands cycle by catalyzing the conversion of lysophospholipids, specifically lysophosphatidic acid (LPA), into phospholipids like phosphatidic acid (PA) through the addition of an acyl group [12, 15]. This enzymatic activity is essential for maintaining the specific lipid composition of organelle membranes, which in turn regulates membrane curvature and the formation of transport tubules [1, 11]. By converting cone-shaped lysophospholipids into cylindrical phospholipids, AGPAT3 acts as a negative regulator of membrane tubulation [10, 12]. Inhibition of this enzyme, notably by the compound CI-976 (PD 128042), leads to an accumulation of lysophospholipids that promote excessive Golgi tubulation and retrograde trafficking from the Golgi to the ER [5, 11]. Consequently, it is a key regulator of Golgi structure and protein trafficking, making it a subject of interest in studies of cellular organization and diseases involving secretory pathway dysfunction, such as cancer [2, 14].
Lysophospholipid acyltransferase inhibition
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 1-acyl-sn-glycerol-3-phosphate acyltransferase 3 (AGPAT3) (AGPAT3).